Sparsentan outperforms irbesartan for treatment of IgAN Presented ByProf. Brad Rovin, Ohio State University, OH, USA TrialPhase 3, PROTECT ConferenceASN 2023 28 November, 2023 14:33
Cemdisiran shows promise in IgA nephropathy Presented ByProf. Jonathan Barratt, University of Leicester, UK TrialPhase 2 ConferenceASN 2022 8 December, 2022 14:58